Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Teles, Flávio ^a   Da Silva, Tarcilo Machado ^a   Da Cruz, Francisco Pessoa ^a   Honorato, Vitor Hugo ^a   De Oliveira Costa, Henrique ^a   Barbosa, Ana Paula Fernandes ^a   De Oliveira, Sabrina Gomes ^a   Porfírio, Zenaldo ^a   Libório, Alexandre Braga ^b   Borges, Raquel Lerner ^c   Fanelli, Camilla ^d  

^a State University of Health Sciences   (Brazil)

^b Univ Fed   (Brazil)

^c UNIVERSITY OF NORTHERN COLORADO   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PLACEBO; POTASSIUM; PROPOLIS; REACTIVE OXYGEN METABOLITE; RED PROPOLIS; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APITHERAPY; ARTICLE; BEE EXTRACT; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; GLOMERULOSCLEROSIS; HYPERTENSION; INFLAMMATORY INFILTRATE; KIDNEY INJURY; MACROPHAGE; MACROPHAGE MIGRATION; MALE; NONHUMAN; OXIDATIVE STRESS; POTASSIUM BLOOD LEVEL; PROTEINURIA; RAT; RAT MODEL; RENAL PROTECTION; WISTAR RAT; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; HYPERTENSION, RENAL; KIDNEY; NEPHRECTOMY; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ANIMALIA; APIS MELLIFERA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CREATININE; DISEASE MODELS, ANIMAL; HYPERTENSION, RENAL; KIDNEY; MALE; NEPHRECTOMY; PROPOLIS; PROTEINURIA; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC;

EID: 84921910997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116535     Document Type: Article

References (49)

1. Grams ME, Chow EK, Segev DL, Coresh J (2013) Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 62:245-252. doi: 10.1053/j.ajkd.2013.03.009 PMID: 23566637
2. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, et al. (2013) Global Kidney Disease: Global dimension and perspectives. Lancet 382: 260-72. doi: 10.1016/S0140-6736(13)60687-X PMID: 23727169
3. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG (1996). Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49:666-678. doi: 10.1038/ki.1996.95 PMID: 8648907
4. Wu LL, Yang N, Roe CJ, Cooper ME, Gilbert CR, et al (1997). Macrophage and myofibroblast proliferation in remnant kidney: Role angiotensin II. Kidney Int 52;S221-S225. PMID: 9407465
5. Fujihara CK, Malheiros DM, Zatz R, Noronha ID (1998) Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54(5):1510-1519. doi: 10.1046/j.1523-1755.1998.00138.x PMID: 9844127
6. Fujihara CK, Malheiros DM, Donato JL, Poli A, De Nucci G, et al. (1998) Nitroflurbiprofwn, a new non-steroidal anti-inflammatory, ameliorates structural injury in the remnant kidney. Am J Physiol 274(3): F573-9 PMID: 9530274
7. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, et al (2003) Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63(1):209-216. doi: 10.1046/j.1523-1755.2003.00736.x PMID: 12472785
8. Gonc¸alves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL (2004). Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: Strong renoprotection by therapy with losartan and a non-steroidal anti-inflammatory. Am. J. Physiol. Renal Physiol. 286:F945-54. doi: 10.1152/ajprenal.00238.2003 PMID: 15075190
9. Himmelfarb J (2004) Linking oxidative stress and inflammation in kidney disease Which is the chicken and which is the egg? Semin Dial. 17:499-54. doi: 10.1111/j.0894-0959.2004.17605.x PMID: 15660575
10. Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM Jr, et al. (2006). Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol 292(1):F92-9.
11. Greenaway W, Scaysbrook T, Whatley FR (1990) The composition and plant origins of propolis. Bee World 71:107-18.
12. Burdock GA (1998) Review of the biological properties and toxicity of bee propolis Food and Chemical Toxicology 36:347-63. doi: 10.1016/S0278-6915(97)00145-2 PMID: 9651052
13. Toreti VC, Sato HH, Pastore GM, Park YK (2013). Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013; 2013:697390. doi: 10.1155/2013/697390 PMID: 23737843
14. Kubota Y, Umegaki K, Kobayashi K, Tanaka N, Kagota S, et al (2004) Anti-hypertensive effects of brazilian propolis in spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 31,S29-S30 doi: 10.1111/j.1440-1681.2004.04113.x PMID: 15649281
15. Maruyama H, Sumitou Y, Sakamoto T, Araki Y, Hara H (2009) Antihypertensive Effects of Flavonoids Isolated from Brazilian Green Propolis in Spontaneously Hypertensive Rats. Biol Pharm Bull 32(7) 1244-1250. doi: 10.1248/bpb.32.1244 PMID: 19571393
16. Morello S, Vellecco V, Alfieri A, Mascolo N, Cicala C (2006) Vasorelaxant effect of the flavonoid galangin on isolated rat thoracic aorta. Life Sci 18; 78(8):825-30. doi: 10.1016/j.lfs.2005.05.072 PMID: 16169019
17. Silva BB, Rosalen PL, Cury JA, Ikegaki M, Souza VC, et al (2008) Chemical composition and botanical origin of Red Propolis, a new type of Brazilian propolis. Evid Based Complement Alternat Med 5(3) 313-6. doi: 10.1093/ecam/nem059 PMID: 18830449
18. Arias SC, Valente CP, Machado FG, Fanelli C, Origassa CS, et al (2013) Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy. PLoS One 8(2):e56215. doi: 10.1371/journal.pone.0056215 PMID: 23431367
19. Li YJ, Lin JL, Yang CW, Yu CC (2005) Acute renal failure induced by a Brazilian variety of propolis. Am J Kidney Dis 46(6):e125-9. doi: 10.1053/j.ajkd.2005.08.028 PMID: 16310564
20. Smith WR, Neill J, Cushman WC, Butkus DE (1989) Captopril-associated acute interstitial nephritis. Am J Nephrol. 9(3):230-5. doi: 10.1159/000167970 PMID: 2527007
21. Mishima S, Yoshida C, Akino S, Sakamoto T (2005) Antihypertensive Effects of Brazilian Propolis: Identification of Caffeoylquinic Acids as Constituents Involved in the Hypotension in Spontaneously Hypertensive Rats. Biol Pharm Bull 28(10): 1909-1914. doi: 10.1248/bpb.28.1909 PMID: 16204944
22. Oršoli N, Sirovina D, Konči MZ, Lacković G, Gregorović G (2012) Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complement Altern Med 6; 12:117. doi: 10.1186/1472-6882-12-117 PMID: 22866906
23. Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM (2009). Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters. Pak J Pharm Sci 22:205-10. PMID: 19339234
24. Kitamura H, Naoe Y, Kimura S, Miyamoto T, Okamoto S, et al (2013) Beneficial effects of Brazilian propolis on type 2 diabetes in ob/ob mice: Possible involvement of immune cells in mesenteric adipose tissue. Adipocyte 1; 2(4):227-36. doi: 10.4161/adip.25608 PMID: 24052898
25. Ahn MR, Kumazawa S, Hamasaka T, Bang KS, Nakayama T (2004) Antioxidant activity and constituents of propolis collected in various areas of Korea. J Agric Food Chem 1; 52(24):7286-92. doi: 10.1021/jf048726s PMID: 15563208
26. Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KM, et al (2013) Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem 15; 21(24):7570-7. doi: 10.1016/j.bmc.2013.10.044 PMID: 24262889
27. Teles F, Machado FG, Ventura BH, Malheiros DM, Fujihara CK, et al (2009) Regression of glomerular injury by losartan in experimental diabetic nephropathy. Kidney Int 75(1):72-79. doi: 10.1038/ki.2008.528 PMID: 18946500
28. Fujihara CK, Malheiros DMAC, Zatz R (2007) Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. Am J Physiol Renal Physiol 292:F1810-F1818. doi: 10.1152/ajprenal.00521.2006 PMID: 17344184
29. Fujihara CK, Velho M, Malheiros DM, Zatz R (2005) An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 67(5):1913-24. doi: 10.1111/j.1523-1755.2005.00290.x PMID: 15840039
30. de Faria JB Lopes, Silva KC, de Faria JM Lopes (2011) The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res 34(4):413-22. doi: 10.1038/hr.2010.263 PMID: 21228783
31. Parving HH, Andersen AR, Hommel E, Smidt U (1985) Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension. 7(6,2):II114-7. doi: 10.1161/01.HYP.7.6-Pt-2.II114 PMID: 4077229
32. Cicala C, Morello S, Iorio C, Capasso R, Borrelli F, et al (2003) Vascular effects of caffeic acid phenethyl ester (CAPE) on isolated rat thoracic aorta. Life Sci 23; 73(1):73-80. doi: 10.1016/S0024-3205(03)00235-2 PMID: 12726888
33. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, et al (2007) Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation and progressive injury in renal mass reduction. J Pharmacol Exp Ther 323 (1):85-93. doi: 10.1124/jpet.107.123638 PMID: 17636006
34. Yang N, Wu LL, Nikolic-Paterson DJ, Ng YY, Yang WC, et al (1998) Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant. Nephrol Dial Transplant 13:1967-1974. doi: 10.1093/ndt/13.8.1967 PMID: 9719149
35. Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12(2):135-142. doi: 10.1007/s11906-010-0100-z PMID: 20424957
36. Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ (2001) The role of immunocompetent cells in non-immune renal diseases. Kidney Int 59(5):1626-40. doi: 10.1046/j.1523-1755.2001.0590051626.x PMID: 11318933
37. Shimizu MHM, Coimbra TM, De Araujo M, Menezes LF, Seguro AC (2005) NAC attenuates chronic renal failure progression. Kidney Int 68, pp.2208-2217. doi: 10.1111/j.1523-1755.2005.00677.x PMID: 16221220
38. Ghosh SS, Krieg R, Massey HD, Sica DA, Fakhry I, et al (2012) Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Renal Physiol 15; 302(4):F439-54. doi: 10.1152/ajprenal.00356.2010 PMID: 22031851
39. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C (2007) Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 292(5):F1404-F1410. doi: 10.1152/ajprenal.00260.2006 PMID: 17200156
40. Nagai T, Inoue R, Inoue H, Suzuki N (2003) Preparation and antioxidant properties of water extract of propolis. Food Chemistry 80:29-33.
41. Khayyal MT, Elghazaly MA, El-Khatib AS (1993) Mechanisms involved in the anti-inflammatory effect of propolis extract. Drugs Under Experimental and Clinical Research 19:197-203. PMID: 7513636
42. Tohamy AA, Abdella EM, Ahmed RR, Ahmed YK (2014) Assessment of anti-mutagenic, anti-histopathologic and antioxidant capacities of Egyptian bee pollen and propolis extracts. Cytotechnology 66 (2):283-97. doi: 10.1007/s10616-013-9568-0 PMID: 23677589
43. Zhu W, Chen M, Shou Q, Li Y, Hu F (2011) Biological activities of chinese propolis and brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in rats. Evid Based Complement Alternat Med. 2011:468529. doi: 10.1093/ecam/neq025 PMID: 21785625
44. Fanelli C, Zatz R (2011) Linking oxidative stress, the renin-angiotensin system, and hypertension Hypertension 57(3):373-4. doi: 10.1161/HYPERTENSIONAHA.110.167775 PMID: 21282556
45. Jaimes EA, Galceran JM, Raij L (1998) Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54(3):775-784. doi: 10.1046/j.1523-1755.1998.00068.x PMID: 9734602
46. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK (2003) Oxidative Stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63(1):179-185. doi: 10.1046/j.1523-1755.2003.00702.x PMID: 12472781
47. Vienet R, Grognet JM, Ezan E, Lecaque D, Hamon G, et al (1994) Effect of chronic converting-enzyme inhibition on kidney function of senescent hypertensive rats. J Cardiovasc Pharmacol 23 Suppl 4:S19-25. PMID: 7527097
48. Ruiz-Muñoz LM, Vidal-Vanaclocha F, Lampreabe I (1997) Enalapril inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations. Nephrol Dial Transplant 12 (3):456-64. doi: 10.1093/ndt/12.3.456 PMID: 9075124
49. Banday AA, Lokhandwala MF (2011) Oxidative stress causes renal angiotensin II type 1 receptor upregulation, Na+/H+ exchanger 3 overstimulation, and hypertension. Hypertension 57(3):452-9 doi: 10.1161/HYPERTENSIONAHA.110.162339 PMID: 21282559